Related Topics

LinkedIn
Vimeo
Facebook

Technology Platform

Genea Biocells technology platform is founded on over 10 years of stem cell R&D. We developed one of the world’s largest banks of diverse, ethically derived, NIH approved human embryonic stem cells and the world’s first scalable, high-yield differentiation protocol for skeletal muscle cells.

Preclinical Drug Candidates

 

Stem Cell Bank

We developed one of the world’s largest banks of diverse, ethically derived, NIH approved human embryonic stem cell lines

Learn More
Skeletal Muscle Differentiation

We developed the world’s first protocol to differentiate pluripotent stem cells to skeletal muscle with high yields and without cell sorting or genetic manipulation

Learn More
Neuronal Differentiation

We developed protocols to generate neural progenitor cells and further differentiate them towards GABAergic, glutamatergic and motor neurons

Learn More
Chemical Genomics

We were amongst the first to systematically use high-throughput screening to modulate pluripotency maintenance and differentiation of stem cells

Learn More